These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1364172)

  • 1. Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implications.
    Roncalli M; Doglioni C; Springall DR; Papotti M; Pagani A; Polak JM; Ibrahim NB; Coggi G; Viale G
    Diagn Mol Pathol; 1992 Jun; 1(2):129-35. PubMed ID: 1364172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent mutations of the p53 gene in pulmonary carcinoid tumors.
    Lohmann DR; Fesseler B; Pütz B; Reich U; Böhm J; Präuer H; Wünsch PH; Höfler H
    Cancer Res; 1993 Dec; 53(23):5797-801. PubMed ID: 8242638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
    Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
    Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids.
    Komminoth P; Roth J; Lackie PM; Bitter-Suermann D; Heitz PU
    Am J Pathol; 1991 Aug; 139(2):297-304. PubMed ID: 1651057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
    Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
    Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms.
    Barbareschi M; Girlando S; Mauri FA; Arrigoni G; Laurino L; Dalla Palma P; Doglioni C
    J Pathol; 1992 Apr; 166(4):343-50. PubMed ID: 1355531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis.
    Wang DG; Johnston CF; Anderson N; Sloan JM; Buchanan KD
    J Pathol; 1995 Apr; 175(4):397-401. PubMed ID: 7790993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alteration in carcinoid tumors of the lung.
    Sugio K; Osaki T; Oyama T; Takenoyama M; Hanagiri T; Morita M; Yamazaki K; Nagashima A; Nakahashi H; Maehara Y; Yasumoto K
    Ann Thorac Cardiovasc Surg; 2003 Jun; 9(3):149-54. PubMed ID: 12875635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
    Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
    Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of p53 mutations in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.
    Wang X; Rao MS; Yeldandi AV
    Mod Pathol; 1995 Dec; 8(9):919-23. PubMed ID: 8751332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.